chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The one that began on 3/2/2021 and continues non-stop  is a headache with head pressure 24 hours per day, 7 days per week.  Now, I was diagnosed with Shingles on 4/14/2021.  Starting at 8:30 PM on 3/2/2021, I had dizzy spells that subsided on 4/14/21.  I also had groin pain which lasted until recently. Other symptoms on 3/2/2021 which lasted a few days were: high temperature, intense arm pain at injection site, teeth hurt, neck hurt, sinus pain & pressure, ear pressure, chills, intense nausea, leg pains especially of right leg on which I could not put pressure or weight, balance issues, exhaustion, rash on face & around eyes, across nose & on cheeks
This is a spontaneous report received from a contactable physician (who is also the patient). A 33-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular in the left arm, on 18Jan2021 08:00 (lot number: el3248, expiry date: unknown), at single dose; and received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular in the left arm, on 18Jan2021 14:00 (lot number: EL0140, expiry date: unknown), at single dose, for covid-19 immunization, at the hospital (this was also reported as received the first dose on 18Jan2021 14:00 and the second dose on 18Jan2021 08:00, pending clarification). The patient medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the BNT162B2 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The patient experienced shoulder tenderness, joint pain, chills and lethargy on 18Jan2021 at 17:30. No treatment was given for the events. The patient recovered from the events on an unspecified date. The events were assessed as non-serious.  No follow-ups attempts are possible. No further information is expected.
Delirious; Hands hurt / hands they were so painful; barely get to my bed / ould not even get to the phone; fever shot up so high; Shivering; shaking for hours; This case was reported by a consumer via call center representative and described the occurrence of delirium in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (intramuscular). On an unknown date, unknown after receiving Shingrix, the patient experienced delirium (serious criteria GSK medically significant), pain in hand, activities of daily living impaired, fever, shivering and tremor. On an unknown date, the outcome of the delirium, pain in hand, activities of daily living impaired, fever, shivering and tremor were not recovered/not resolved.   It was unknown if the reporter considered the delirium, pain in hand, activities of daily living impaired, fever, shivering and tremor to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient reported case for herself. after vaccination the patient could barely get to her bed, her hands hurt so bad. Her fever shot up so high and she was shivering and shaking for hours , her hands they were so painful. The patient thought they were gonna come off and patient was so delirious. The patient could not even get to the phone. The permission to follow up denied.
This spontaneous report as received from a medical assistant also reported as healthcare worker refers to an unspecified group of patients of unknown demographics. Patients' medical histories were not provided. On an unknown date in 2014, the patients were vaccinated with doses of ROTATEQ (dose, frequency, and lot # were not reported, orally) which were exposed to an unsupported temperature excursion since 02-NOV-2014. Concomitant medication was not reported. The reporting medical assistant was not aware of any adverse effects. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Redness about an hour after injection-pain for 7 days Redness was about 2" x 1/2 ". There was a line that appeared to be a broken vessell near site. Hot to touch for 5 days and had a hard knot Took Benadryl and Ibuprofen first 2 days and ice pack
COVID 19 Treatment; COVID 19 Treatment; Dose 3: Pfizer/BioNTech, dose 4: Moderna bivalent; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 10Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 33 years for covid-19 immunisation; coviD-19 vaccine nrvv MVa (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), on 30Sep2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "MS" (unspecified if ongoing). Concomitant medication(s) included: FLUOXETINE, start date: 25Oct2019; OCREVUS, start date: 25Oct2019. Past drug history included: Bactrim, reaction(s): "known allergies: Bacrtrim", notes: known allergies: Bacrtrim. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 30Sep2022, outcome "unknown", described as "Dose 3: Pfizer/BioNTech, dose 4: Moderna bivalent"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (26Dec2022) Negative, notes: Tested negative on day 7 with no symptoms remaining; (29Dec2022) Positive, notes: On day 10 had runny nose and fatigue and tested positive again. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Systemic: Exhaustion / Lethargy-Medium, Systemic: Flushed / Sweating-Medium, Additional Details: Pt fainted right after receiving his 1 dose. Temperature taken before vaccine adminstration was 97.3 and blood pressure after fainting was 110/64 (normal).Ptleft with his mother and was advised to seek medical advise from his PCP.
I gave Bivalent vaccine as a primary dose by mistake. Pt waited 15 min after vaccine was given and she tolerated very well.  There was no reaction to the vaccione.
Large erythema-itches-hot to touch-non tender-no groin nodes. Good R.O.M. First noted 3/15/07-increased size 3/16/07.
First shot (Feb 6) was very high on left arm. I waited 15 minutes at sight, but no adverse reaction. The next day, arm was in severe pain. Not at injection sight, from shoulder to elbow. It subsided after one day.  (it didn?t go away, just not as painful, but uncomfortable at night while sleeping)  Received second shot (Feb 26) not quite as high on the same left arm.  Arm  still hurt when moved certain ways during the day-night was still uncomfortable. As time has passed, it has gotten more sore during the day, pangs during the day in the shoulder, upper arm, elbow, arm and wrist. At night, the pain has been unbearable, waking me up every night with  pain in shoulder, arm, elbow and arm. I have used menthol patches, and taken Aleve to relieve the pain, but still every night I wake up due to pain. Went to doctor yesterday, he said the pain is in my tendon and gave me anti inflammatory  Dicflofenac. I have a follow up appt in 3 weeks- if no improvement, we will start physical therapy. I took my first Dicflofenac  last night before bed. I was in more pain then ever!!!!
Patient transferred to the hospital on 01/24/2022.  PMH AML diagnosed 11/2020, s/p allogeneic SCT 3/2021, complicated by chronic GVHD of the skin, currently on Xospata and Tanolimus) and DVT (d/t PICC line, previously on eliquis, stopped 11/2021) who was admitted to the CCU for acute hypoxic respiratory failure due to COVID pneumonia. Patient says he has had symptoms for about a week- intermittent fevers, fatigue, and SOB. He went to an urgent care on 1/19 and was diagnosed with COVID. He received a prescription for molnupiravir Patient stated SOB has gotten progressively worse, to the point that it was hard just walking around the room. He was measuring his pulse oximetry at home and his SPO2 was in the 70s on room air. He went to the hospital and his room air Sp02 was 55%. This improved on 15L high flow NC with a NRB.  Troponin was elevated at .06, lactic acid was 2.5. CTA chest was negative for PE. He received 1 L NS, albuterol, dexamethasone 10, azithromycin, rocephin. PT was transferred to CCU  and placed on max vapotherm.  Patient eventually intubated.  Fungus noted in sputum.  Patient terminally extubated on 02/20/2022 and expired shortly after.
Pt. was woken by muscle spasming on L arm (elbow area) and then over the following 48 hours - arm was getting continued weakness and pain throughout the L arm with tingling of thumb, first 2 fingers and 1/3 of the 3rd finger (ring finger).
an oval shape patch at the injection site that was very red and approximately 3 by 3 inches in size; Itchiness; injection site was tender initially; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness), INJECTION SITE PAIN (injection site was tender initially) and VACCINATION SITE ERYTHEMA (an oval shape patch at the injection site that was very red and approximately 3 by 3 inches in size) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced INJECTION SITE PAIN (injection site was tender initially). On 20-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness). On 21-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (an oval shape patch at the injection site that was very red and approximately 3 by 3 inches in size). On 14-Mar-2021, INJECTION SITE PAIN (injection site was tender initially) outcome was unknown. At the time of the report, VACCINATION SITE PRURITUS (Itchiness) and VACCINATION SITE ERYTHEMA (an oval shape patch at the injection site that was very red and approximately 3 by 3 inches in size) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information included cold compress to relieve the itchiness.
This spontaneous report as received from a Nurse Practitioner refers to patient of unknown age and gender. On an unknown date the patient was vaccinated with GARDASIL (dose, route, lot number and expiration date not reported). There was no concomitant medication reported. The nurse reported that possibly the patient was administered improperly stored GARDASIL on unspecified date. No adverse effects reported. This is one of two reports from the same source. Additional information has been requested.
I received my second dose of Pfizer's Covid vaccine on 1/9/21.  The person who gave the vaccine administered it SQ, not IM.  I did develop a cellulitis like reaction to the area.  The redness began almost immediately following the vaccine, however, the following 2 days the area grew larger and hot to touch.  The area currently is red and itchy, however, swelling and warmth is gone.  My concern is the efficacy of the vaccine since it was not given IM.
Inability to move within 24 hours - lasting 48+ hours Vomiting Pain in left (shot) arm radiating to left breast Rash Headache on the first day Chest pain/tightness, consistent shortness of breath, worse with exertion Brain fog Fatigue Inability to concentrate Very acute depression in the first 3-4 days after the 2nd shot
No additional AE details reported; Administered an expired dose of PROQUAD; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. Concomitant therapies included sterile diluent (STERILE DILUENT). Patient's concurrent conditions and medical history were not provided.  On 22-DEC-2021, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD), 0.5 milliliter (lot # T021639 and expiration date reported as 21-DEC-2021) for prophylaxis (expired product administered). No additional AE details or PQC.
This adult male (unknown age) took the first dose of VIVOTIF (Batch no. : unknown) on unknown date.  Within one day he experienced severe nausea why he was unable to go to work.  The patient didn't continue with the oral typhoid immunization.  Unknown recovery status.  Follow-up information was requested on 07.Apr.2008 and 05.May.2008 by PV Crucell, Berna Products tried to reach the patient by phone.  No further information was received.
12/16/2019. Shot administered at 11:06 am Are immediately started to ache.  Continues to get worse as the day went on.  Put heat/cold took Advil that evening.  Continues to ache. Called pharmacy a few days later, told me it was a high dose and what I was feeling common.  Went to Walk in Clinic 1/13/2020.  Prescribed  Methylprednisolone 4 MG.  Pain in my arm went completely away while on the steroid. Day after I finished there prescription the pain came back even worse
Pt's wife called in AM saying pt had hives 1 day post vaccine - 11/10/14. She said pt will come in to ask for how to treat hives - pt came later and showed me his hives - per back of head -> toe, arms, body -> told pt to get BENADRYL and see MD in 2 days if Sx's not persisted.
fever (2 days), chills (2 days), nausea (waves on and off 4 days), severe headache(4 days), body aches (3 days), neck pain (4 days). I still get a headache once a day since the vaccine
Pt c/o lightheadedness after getting the vaccine. Pt brought to triage area and was monitored. Pt given water. BP 93/57, HR 59, RR 18; 95/61, 65, 18; 105/70, 66, 18.  Pt stated that he feels better and his symptoms have improved over ~15mins. Pt stable and released from vaccination site with father.
pt recvd vax & had a syncopal or vasovagal episode; pt recovered w/o any residula effects; No further details were provided;
critical sadness like never before/sadness and depression; Flu like symptoms; terribly sick; nausea; lethargy; body ache; fatigue (he is tired all the time and cannot get off the couch); This is a spontaneous report from a contactable consumer (patient) via a Pfizer. A 54-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm right on 22Apr2021 (Batch/Lot Number: EW0162; Expiration Date: Jul2021) as 1st dose, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included gabapentin (GABAPENTIN) taken for neuropathy peripheral, start and stop date were not reported.  Patient stated that after receiving the first dose of the Pfizer Covid-19 vaccine on 22Apr2021, he has been terribly sick, he feel like his dying. He had nausea, lethargy, body ache, critical sadness like never before, fatigue (he was tired all the time and cannot get off the couch) and it was not going away on 23Apr2021. He had seen three doctors, tested negative to Covid-19 and his blood tests were normal. He had flu like symptoms for 13 days since 23Apr2021, and it never goes away. The symptoms seem to get better and then he exercises a lot and they come back. Patient has been nauseated, had extreme lethargy, sadness and depression, and body aches. The patient was on a plethora of medications now because of this. He wanted to know what does it say about his immune system? He was scared that he was dying, it feels like he's dying. He has worn two masks and not socialized at all and does not understand what has happened, he has done everything right. His inflammatory response was checked on 04May2021 which has not come back yet. The patient underwent lab tests and procedures which included blood test: normal on 06May2021, body height: 175 cm on 06May2021, platelet count: normal on 04May2021, red blood cell count: normal   on 04May2021, sars-cov-2 test: negative on 04May2021, weight: 195-200 on 06May2021. He wanted to know when will these side effects go away and he will start getting better, and asked if he should get the second dose. Outcome of the events was not recovered.
experiencing sores around those implants/quite painful; hard to chew; the regions are blackening.; "I" have implants and I am experiencing sores around those implants; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Apr2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included dental implant. Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an an unknown date as a single dose for COVID-19 immunisation. The patient had implants and on 26Apr2021 the patient experienced sores around those implants which makes it hard to chew and were quite painful, also those regions were blackening. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sores around those implants which makes it hard to chew and were quite painful and also those regions were blackening, were not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Symptoms of SOB , difficulty breathing, cough, and weakness started 8/12/2021, admitted 8/23/2021 with  acute hypoxemic respiratory failure secondary to Covid-19 PNA.
Pain in left arm at injection site, swelling and pain of lymph node in left armpit, headache, nausea, fever, body aches
I received the Moderna COVID-19 Vaccine EUA on the morning of 1/14/21. The next morning when I woke up I noticed that my right jaw was sore. I thought I may have slept on it wrong during my sleep or that had chewed weird while eating the day before and didn't think much of it. Throughout the day on 1/15/21 I continued to experience more pain though. I put some heat on it and tried to massage it, but nothing really helped. I hoped it would feel better this morning( 1/16/21) when I woke up but at this point it feels about the same. It's difficult to chew and feels swollen because my mouth bite isn't fully aligned like it usually is. I took my temperature and don't have a fever. I thought I should submit this in case my jaw pain it is related to getting the vaccine. In the past (maybe a year or so ago) I did have my chiropractor do some muscle release on the right side of my jaw because it was clicking a little while I ate and he said it was TMJ. I haven't experienced that since and this does not feel like that did, nor is there any clicking. Maybe that made me or susceptible though to experience this side effect if that's what it is so wanted to include that too.
No adverse event; monovalent vaccine "Booster dose only" presentation administered instead of  bivalent; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (monovalent vaccine "Booster dose only" presentation administered instead of  bivalent) and NO ADVERSE EVENT (No adverse event) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR6965B) for COVID-19 vaccination.     The patient had no medical history related to mentioned adverse events, both acute and chronic illness at the time of vaccination. No other vaccines were given within 1 month prior to Moderna COVID-19 vaccine.     On 05-Nov-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2022, the patient experienced WRONG PRODUCT ADMINISTERED (monovalent vaccine "Booster dose only" presentation administered instead of  bivalent). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (monovalent vaccine "Booster dose only" presentation administered instead of  bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (monovalent vaccine "Booster dose only" presentation administered instead of  bivalent).    No concomitant medication was reported.  No treatment medication was reported. The patient did not report any adverse event. The information was unknown whether the patient was provided any treatment or concomitant or regular medication.
Patient experienced excruciating pain in arm several hours after PNEUMOVAX administration. Patient still has some soreness and has been using ALEVE, EXCEDRIN, ice and a heating pad.
Pt received shot Fri - Pt brought in Monday to be seen. Noted markedly erythematous area that measures probably 3 x 2 cm. around that faint redness 0 tender 0 warm 0 infection noted. Additional information . Tuesday 6/02/09 mother was asked to bring child in for follow-up. Mother declined states legs reddened and has no further concerns, but will call if necessary.
patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent).    No concomitant product reported by reporter. No treatment medication reported by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live non-significant follow up received. Narrative updated..
BREAKTHROUGH COVID INFECTION. PATIENT TESTED POSITIVE ON 10/21/2021. PATIENT FULLY VACCINATED ON 03/14/2021.